These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 17108870

  • 21. Liver cancer stem cells: implications for a new therapeutic target.
    Lee TK, Castilho A, Ma S, Ng IO.
    Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
    [Abstract] [Full Text] [Related]

  • 22. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
    Renard CA, Labalette C, Armengol C, Cougot D, Wei Y, Cairo S, Pineau P, Neuveut C, de Reyniès A, Dejean A, Perret C, Buendia MA.
    Cancer Res; 2007 Feb 01; 67(3):901-10. PubMed ID: 17283120
    [Abstract] [Full Text] [Related]

  • 23. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
    Bai XM, Zhang W, Liu NB, Jiang H, Lou KX, Peng T, Ma J, Zhang L, Zhang H, Leng J.
    Oncol Rep; 2009 Jan 01; 21(1):129-36. PubMed ID: 19082453
    [Abstract] [Full Text] [Related]

  • 24. Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.
    Braeuning A, Menzel M, Kleinschnitz EM, Harada N, Tamai Y, Köhle C, Buchmann A, Schwarz M.
    FEBS J; 2007 Sep 01; 274(18):4766-77. PubMed ID: 17697114
    [Abstract] [Full Text] [Related]

  • 25. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
    Zhao J, Dong L, Lu B, Wu G, Xu D, Chen J, Li K, Tong X, Dai J, Yao S, Wu M, Guo Y.
    Gastroenterology; 2008 Sep 01; 135(3):956-68. PubMed ID: 18555021
    [Abstract] [Full Text] [Related]

  • 26. [Laminin and its alpha 6 integrin receptor in the regulation of human hepatocellular carcinoma cell phenotypes].
    Lu TJ, Zhang QY, Zhou RL.
    Zhonghua Zhong Liu Za Zhi; 2003 Jan 01; 25(1):31-5. PubMed ID: 12678983
    [Abstract] [Full Text] [Related]

  • 27. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
    Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J.
    J Hepatol; 2008 Jul 01; 49(1):61-71. PubMed ID: 18466996
    [Abstract] [Full Text] [Related]

  • 28. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y, Yoon JW, Xiao X, Dean NM, Monia BP, Marcusson EG.
    Cancer Res; 2007 Apr 15; 67(8):3583-93. PubMed ID: 17440069
    [Abstract] [Full Text] [Related]

  • 29. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
    Lee HS, Park MH, Yang SJ, Park KC, Kim NS, Kim YS, Kim DI, Yoo HS, Choi EJ, Yeom YI.
    Life Sci; 2007 Jan 23; 80(7):690-8. PubMed ID: 17157329
    [Abstract] [Full Text] [Related]

  • 30. Effect of phorbol 12-myristate-13-acetate on cell adhesion in SMMC-7721 human hepatocellular carcinoma cell line and its mechanism.
    Fu JZ, Zha XL.
    J Exp Clin Cancer Res; 1998 Jun 23; 17(2):153-7. PubMed ID: 9700575
    [Abstract] [Full Text] [Related]

  • 31. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 23; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

  • 32. Role and significance of focal adhesion proteins in hepatocellular carcinoma.
    Yam JW, Tse EY, Ng IO.
    J Gastroenterol Hepatol; 2009 Apr 23; 24(4):520-30. PubMed ID: 19368632
    [Abstract] [Full Text] [Related]

  • 33. Rho GTPase and Wnt signaling pathways in hepatocarcinogenesis.
    Lechel A, Rudolph KL.
    Gastroenterology; 2008 Mar 23; 134(3):875-8. PubMed ID: 18325396
    [No Abstract] [Full Text] [Related]

  • 34. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E, Goldenberg D.
    Mol Cancer Res; 2007 Nov 23; 5(11):1159-70. PubMed ID: 18025261
    [Abstract] [Full Text] [Related]

  • 35. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R, Rahn S, Pollrich K, Hertel J, Dittmar Y, Hommann M, Henklein P, Biskup C, Westermann M, Hollenberg MD, Settmacher U.
    J Cell Physiol; 2007 Jun 23; 211(3):699-707. PubMed ID: 17323377
    [Abstract] [Full Text] [Related]

  • 36. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC.
    Endocr Relat Cancer; 2007 Jun 23; 14(2):513-29. PubMed ID: 17639064
    [Abstract] [Full Text] [Related]

  • 37. Bone marrow cells: the source of hepatocellular carcinoma?
    Wu XZ, Yu XH.
    Med Hypotheses; 2007 Jun 23; 69(1):36-42. PubMed ID: 17300877
    [Abstract] [Full Text] [Related]

  • 38. Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition.
    Imamichi Y, Menke A.
    Cells Tissues Organs; 2007 Jun 23; 185(1-3):180-90. PubMed ID: 17587824
    [Abstract] [Full Text] [Related]

  • 39. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY, Cheng AL.
    Cancer Res; 2008 Aug 15; 68(16):6698-707. PubMed ID: 18701494
    [Abstract] [Full Text] [Related]

  • 40. [Partial reversion of the phenotype of a poorly differentiated hepatocellular carcinoma in a three-dimensional culture].
    Rudinskaia TD, Kuprina NI, Lazarevich NL, Polianskaia NI, Poltoranina VS, Shavochkina DA, Engel'gardt NV.
    Ontogenez; 2010 Aug 15; 41(1):58-65. PubMed ID: 20184122
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.